278 related articles for article (PubMed ID: 19077818)
1. Implantable cardioverter defibrillator therapy for patients with less severe left ventricular dysfunction.
Exner DV
Curr Opin Cardiol; 2009 Jan; 24(1):61-7. PubMed ID: 19077818
[TBL] [Abstract][Full Text] [Related]
2. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Andrews ML; Hall WJ; Greenberg H; Case RB;
Am J Cardiol; 2006 Aug; 98(4):485-90. PubMed ID: 16893702
[TBL] [Abstract][Full Text] [Related]
3. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML;
J Am Coll Cardiol; 2007 Apr; 49(13):1427-33. PubMed ID: 17397670
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
Franqui-Rivera H; Sotomonte JC
P R Health Sci J; 2011 Jun; 30(2):78-83. PubMed ID: 21682151
[TBL] [Abstract][Full Text] [Related]
5. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
8. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
Nanthakumar K; Epstein AE; Kay GN; Plumb VJ; Lee DS
J Am Coll Cardiol; 2004 Dec; 44(11):2166-72. PubMed ID: 15582314
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).
Greenberg H; Case RB; Moss AJ; Brown MW; Carroll ER; Andrews ML;
J Am Coll Cardiol; 2004 Apr; 43(8):1459-65. PubMed ID: 15093884
[TBL] [Abstract][Full Text] [Related]
11. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies.
Aktas MK; Kim DD; McNitt S; Huang DT; Rosero SZ; Hall BW; Zareba W; Daubert JP
Pacing Clin Electrophysiol; 2009 Dec; 32(12):1501-8. PubMed ID: 19793373
[TBL] [Abstract][Full Text] [Related]
13. ICD therapy: 'the sickest benefit the most...': what about the less sick?
Kuck KH; Nisam S
Europace; 2006 Jul; 8(7):508-11. PubMed ID: 16760232
[TBL] [Abstract][Full Text] [Related]
14. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
Triedman JK
Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
[No Abstract] [Full Text] [Related]
15. Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk.
Kamath GS; Mittal S; Sherrid MV
Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():32-40. PubMed ID: 20089485
[TBL] [Abstract][Full Text] [Related]
16. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
18. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
Prystowsky EN
Rev Cardiovasc Med; 2003; 4 Suppl 2():S47-54. PubMed ID: 12776013
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
[TBL] [Abstract][Full Text] [Related]
20. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
